Cargando…
NLRP3 inflammasome as a potential treatment in ischemic stroke concomitant with diabetes
The NLRP3 (nucleotide-binding oligomerization domain-like receptor [NLR] family pyrin domain-containing 3) inflammasome is a member of the NLR family of innate immune cell sensors. These are crucial regulators of cytokine secretions, which promote ischemic cell death and insulin resistance. This rev...
Autores principales: | Hong, Pu, Gu, Ruo-Nan, Li, Feng-Xian, Xiong, Xiao-Xing, Liang, Wen-Bin, You, Zhi-Jian, Zhang, Hong-Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554993/ https://www.ncbi.nlm.nih.gov/pubmed/31174550 http://dx.doi.org/10.1186/s12974-019-1498-0 |
Ejemplares similares
-
Inhibition of NLRP3 Inflammasome Ameliorates Cerebral Ischemia-Reperfusion Injury in Diabetic Mice
por: Hong, Pu, et al.
Publicado: (2018) -
NLRP3 Inflammasome: A Potential Target in Isoflurane Pretreatment Alleviates Stroke-Induced Retinal Injury in Diabetes
por: Lin, Hong-Bin, et al.
Publicado: (2021) -
Trends in NLRP3 inflammasome research in ischemic stroke from 2011 to 2022: A bibliometric analysis
por: Zhu, Hua, et al.
Publicado: (2023) -
Inhibition of NLRP3 Inflammasome: A Prospective Target for the Treatment of Ischemic Stroke
por: Feng, Ya-Shuo, et al.
Publicado: (2020) -
Pharmacological intervention of curcumin via the NLRP3 inflammasome in ischemic stroke
por: Du, Xiaoxue, et al.
Publicado: (2023)